🟢 Protara Therapeutics is trading 10% up in pre-market with no clear catalyst

Protara Therapeutics is trading at $3.35, up 9.84%, in pre-market, with no clear company-specific catalyst identified.

• The latest company announcement found was dated September 8, 2026.
• A September 30 report also described the prior decline as having no clear catalyst; the reason for the overnight rebound remains unclear.